Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Hyderabad doctor loses Rs 4.7 crore in stock market investment scam

Ahmedabad-Based Troikaa Pharma Falls Victim To Rs 50 Lakh Cyber Fraud

Farhat Nasim9 April 2025 5:38 PM IST

Ahmedabad: An Ahmedabad-based pharmaceutical company has become the latest victim of a sophisticated cyber fraud involving email spoofing and forged...

Dettol Controversy: Reckitt Settles with Influencer Raj Shamani, But To Proceed Legally Against Dermatologist

Dettol vs. Dermatologist: HC Orders Influencer to Delete Disparaging Claims

Farhat Nasim8 April 2025 7:33 PM IST

New Delhi: In relief to Reckitt Benckiser (India) Limited, the Delhi High Court on Tuesday recorded an undertaking by social media influencer Raj...

Dr Reddys Labs secures European Commission approval for biosimilar to treat osteoporosis

Dr Reddy's Slapped Rs 2,395 Cr Income Tax Notice, Pharma Giant Denies Allegations

Farhat Nasim8 April 2025 6:07 PM IST

Hyderabad: The Income Tax Department has issued a show cause notice to Dr Reddy's Laboratories Limited, proposing a tax demand exceeding Rs 2,395...

CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial of Sintilimab Before Phase III Launch

Mankind's KIND Brand Upheld by Delhi HC, KINDPAN Trademark Quashed

Farhat Nasim7 April 2025 5:27 PM IST

New Delhi: In a major relief to Mankind Pharma Limited, the Delhi High Court has directed the removal of the trademark KINDPAN from the Register...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Risdiplam Price Disparity in India vs China, Pakistan: SC Issues Notice to Roche

Farhat Nasim6 April 2025 2:00 PM IST

It was submitted that why can't the Indian government negotiate with Roche to make the medicine for the rare disorder available at a cheaper rate.

CDSCO Launches Online Risk Classification Module for Non-IVD Medical Devices

India's Medical Device Exports to US Hit by 26% Reciprocal Tariff: AiMeD Raises Concerns

Farhat Nasim6 April 2025 11:15 AM IST

New Delhi: The imposition of a 26% reciprocal tariff by the United States on Indian medical device exports has raised serious concerns within the...

Gujarat Govt to Withdraw Dual Pricing Policy on Cardiac Stents, AiMeD Welcomes End to USFDA Bias

Farhat Nasim5 April 2025 4:33 PM IST

New Delhi: In a significant policy reversal, the Gujarat government has withdrawn a contentious dual pricing order for cardiac stents that offered...

Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources

Strides Pharma Recalls Testosterone Gel In US Market

Farhat Nasim5 April 2025 1:27 PM IST

The Chestnut Ridge-based drugmaker, a part of Bengaluru-based Strides Pharma Science, is recalling the affected lot due to the 'Presence of Benzene'.

AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter Market

AbbVie Lowers 2025 Earnings Forecast After USD 20 Billion Acquisition Spree

Farhat Nasim5 April 2025 11:15 AM IST

AbbVie has been focusing on expanding its pipeline since its blockbuster arthritis drug, Humira, lost patent protection in 2023.

Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indication

Bayer Takes Roundup Cancer Case Back to Supreme Court

Farhat Nasim5 April 2025 10:45 AM IST

Bayer has warned U.S. lawmakers it might halt Roundup sales to farmers, unless they can strengthen legal protection against the litigation.

NPPA Expands Ringer Lactate Price List, Adds Five Manufacturers and New Pack Types

NPPA Allows 1.74% Price Hike for Essential Drugs, No Govt Approval Needed

Farhat Nasim27 March 2025 7:48 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has permitted manufacturers to increase the Maximum Retail Price (MRP) of scheduled...

307 Cases of Drug Price Violations Surface, Big Pharma To Face Heat?

Farhat Nasim26 March 2025 8:34 PM IST

New Delhi: The issue of drug pricing violations has come under scrutiny, with the Parliamentary Standing Committee on Chemicals and Fertilizers...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok